In this study, we demonstrated that H-FABP but not BNP was higher in subjects with IR and Mets than in those without these conditions, suggesting that measurement of H-FABP might be suitable to predict the occurrence of myocardial damage in subjects with metabolic disorder. The gene discussed is FABP3; the disease is Other metabolic disease.